Published in Infect Immun on April 04, 2011
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br J Pharmacol (2014) 1.01
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Evidence of promiscuous endothelial binding by Plasmodium falciparum-infected erythrocytes. Cell Microbiol (2014) 0.84
Molecular cloning, sequence characterization and expression analysis of a CD63 homologue from the coleopteran beetle, Tenebrio molitor. Int J Mol Sci (2013) 0.76
Neisseria cinerea isolates can adhere to human epithelial cells by type IV pilus-independent mechanisms. Microbiology (2016) 0.75
Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes. PLoS One (2016) 0.75
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
Binding of hepatitis C virus to CD81. Science (1998) 12.40
Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell (1986) 4.89
The tetraspanin superfamily: molecular facilitators. FASEB J (1997) 4.29
CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol (1998) 4.01
Interactions of pathogenic neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol (2000) 2.74
Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol (1997) 2.67
Trafficking and function of the tetraspanin CD63. Exp Cell Res (2008) 2.64
Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet (1991) 2.54
The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol Microbiol (1991) 2.36
Opc- and pilus-dependent interactions of meningococci with human endothelial cells: molecular mechanisms and modulation by surface polysaccharides. Mol Microbiol (1995) 2.18
Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci (2001) 2.13
Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol Microbiol (1996) 2.08
Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms. J Cell Biol (2008) 1.75
Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology. Mol Biol Cell (2002) 1.69
Profiling of the tetraspanin web of human colon cancer cells. Mol Cell Proteomics (2006) 1.53
Sequence diversity, predicted two-dimensional protein structure, and epitope mapping of neisserial Opa proteins. J Bacteriol (1998) 1.53
EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells. Biochem J (2003) 1.50
EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins. J Biol Chem (2006) 1.50
Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J Immunol (2006) 1.48
CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans. Eur J Immunol (2000) 1.25
Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J Biol Chem (2006) 1.22
Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood (1995) 1.21
Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol Microbiol (1998) 1.18
Tetraspanins in viral infections: a fundamental role in viral biology? J Virol (2005) 1.16
CD63/Pltgp40: a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. Blood (1991) 1.10
Phenotypic variants of meningococci and their potential in phagocytic interactions: the influence of opacity proteins, pili, PilC and surface sialic acids. Microb Pathog (1997) 1.07
A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on chromosome 12. Somatic Cell Genet (1981) 1.04
Inverse relationship between pilus-mediated gonococcal adherence and surface expression of the pilus receptor, CD46. Microbiology (2001) 0.98
A CD63 mutant inhibits T-cell tropic human immunodeficiency virus type 1 entry by disrupting CXCR4 trafficking to the plasma membrane. Traffic (2008) 0.98
Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion. Biochem Biophys Res Commun (2003) 0.97
Infection of epithelial cells by pathogenic neisseriae reduces the levels of multiple lysosomal constituents. Infect Immun (1998) 0.97
Direct binding of the ligand PSG17 to CD9 requires a CD9 site essential for sperm-egg fusion. Mol Biol Cell (2003) 0.94
Identification of meningococcal genes necessary for colonization of human upper airway tissue. Infect Immun (2008) 0.91
Tetraspanin CD81 is required for Listeria monocytogenes invasion. Infect Immun (2009) 0.91
The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect (2009) 0.90
Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections. BioDrugs (2009) 0.90
CEACAM is not necessary for Neisseria gonorrhoeae to adhere to and invade female genital epithelial cells. Cell Microbiol (2001) 0.87
Crystallization of a carbamatase catalytic antibody Fab fragment and its complex with a transition-state analogue. Acta Crystallogr D Biol Crystallogr (2003) 0.77
Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial. Lancet Infect Dis (2010) 2.67
Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J (2003) 2.51
Genome sequence of the necrotrophic plant pathogen Pythium ultimum reveals original pathogenicity mechanisms and effector repertoire. Genome Biol (2010) 2.36
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. Clin Infect Dis (2008) 2.09
Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis (2006) 1.99
Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis (2009) 1.92
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults. Thorax (2011) 1.91
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J Biol Chem (2001) 1.80
Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS (2002) 1.79
Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice. Respir Med (2004) 1.76
Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms. J Cell Biol (2008) 1.75
Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum (2008) 1.73
C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem (2005) 1.69
Global carbon cycle: metabolic balance of the open sea. Nature (2003) 1.59
Age-related loss of CpG methylation in the tumour necrosis factor promoter. Cytokine (2011) 1.58
Changes and regulation of the C5a receptor on neutrophils during septic shock in humans. J Immunol (2013) 1.57
Toll-like receptors in health and disease: complex questions remain. J Immunol (2003) 1.57
Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation. Blood (2004) 1.56
Flavohemoglobin Hmp protects Salmonella enterica serovar typhimurium from nitric oxide-related killing by human macrophages. Infect Immun (2002) 1.53
The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis. J Immunol (2008) 1.52
Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease. Clin Infect Dis (2006) 1.51
Structural basis for iron piracy by pathogenic Neisseria. Nature (2012) 1.50
Nitric oxide metabolism in Neisseria meningitidis. J Bacteriol (2002) 1.49
Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia (2005) 1.47
The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol (2008) 1.45
Differences between asthmatics and nonasthmatics hospitalised with influenza A infection. Eur Respir J (2012) 1.44
Management of meningitis. Clin Med (2005) 1.43
Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J Clin Invest (2005) 1.42
Nitric oxide in chemostat-cultured Escherichia coli is sensed by Fnr and other global regulators: unaltered methionine biosynthesis indicates lack of S nitrosation. J Bacteriol (2006) 1.42
Osmotic tissue expanders in cleft lip and palate surgery: a cautionary tale. J Plast Reconstr Aesthet Surg (2007) 1.42
The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J Biol Chem (2003) 1.41
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax (2012) 1.40
Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa. Infect Immun (2005) 1.37
Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice. BMJ Open (2012) 1.37
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. FASEB J (2006) 1.33
Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. FASEB J (2004) 1.33
Interaction of the Salmonella typhimurium transcription and virulence factor SlyA with target DNA and identification of members of the SlyA regulon. J Biol Chem (2002) 1.32
Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J Infect Dis (2003) 1.28
A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science (2011) 1.27
Complement component 5a (C5a). Int J Biochem Cell Biol (2009) 1.24
C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J Biol Chem (2003) 1.22
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol Rev (2013) 1.22
Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. FASEB J (2012) 1.21
Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J Immunol (2005) 1.19
Distinctive expansion of potential virulence genes in the genome of the oomycete fish pathogen Saprolegnia parasitica. PLoS Genet (2013) 1.18
Invasion by Neisseria meningitidis varies widely between clones and among nasopharyngeal mucosae derived from adult human hosts. Microbiology (2002) 1.17
Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J Biol Chem (2006) 1.17
Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J Virol (2006) 1.15
Regulation of denitrification genes in Neisseria meningitidis by nitric oxide and the repressor NsrR. J Bacteriol (2006) 1.14
Neisseria meningitidis lactate permease is required for nasopharyngeal colonization. Infect Immun (2005) 1.11
The pathogen Neisseria meningitidis requires oxygen, but supplements growth by denitrification. Nitrite, nitric oxide and oxygen control respiratory flux at genetic and metabolic levels. Mol Microbiol (2005) 1.10
Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic Biol Med (2002) 1.10
Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains. Infect Immun (2003) 1.09
Astrocyte function and role in motor neuron disease: a future therapeutic target? Glia (2009) 1.09
Neisseria lactamica protects against experimental meningococcal infection. Infect Immun (2002) 1.09
NsrR: a key regulator circumventing Salmonella enterica serovar Typhimurium oxidative and nitrosative stress in vitro and in IFN-gamma-stimulated J774.2 macrophages. Microbiology (2007) 1.08
Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library. Nat Biotechnol (2003) 1.06
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review. J Infect (2010) 1.06
A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease. FASEB J (2011) 1.05
Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis. Clin Infect Dis (2011) 1.04
Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms. Infect Immun (2006) 1.04
De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation. J Med Chem (2012) 1.04
Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function. Infect Immun (2007) 1.03
Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis (2010) 1.03
Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages. J Leukoc Biol (2004) 1.03
A cardinal role for cathepsin d in co-ordinating the host-mediated apoptosis of macrophages and killing of pneumococci. PLoS Pathog (2011) 1.02
Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults. J Infect Dis (2003) 1.02
Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response. Mol Immunol (2007) 1.01
Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing. AIDS (2007) 1.01
Distinct cell death programs in monocytes regulate innate responses following challenge with common causes of invasive bacterial disease. J Immunol (2010) 1.01
Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens. Vaccine (2006) 1.00
Metabolism of nitric oxide by Neisseria meningitidis modifies release of NO-regulated cytokines and chemokines by human macrophages. Microbes Infect (2007) 0.99
Peroxynitrite toxicity in Escherichia coli K12 elicits expression of oxidative stress responses and protein nitration and nitrosylation. J Biol Chem (2010) 0.99
Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J (2003) 0.98
Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010. Emerg Infect Dis (2011) 0.98
Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion. Biochem Biophys Res Commun (2003) 0.97
Superantigen recognition by HLA class II on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood (2005) 0.97
Cancer patient perceptions about biobanking and preferred timing of consent. Biopreserv Biobank (2014) 0.96
Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses. Infect Immun (2005) 0.96
Post-transcriptional regulation of bacterial motility by aconitase proteins. Mol Microbiol (2004) 0.96
Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site. J Biol Chem (2005) 0.95
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. J Biol Chem (2006) 0.95
Choline-binding protein A of Streptococcus pneumoniae elicits chemokine production and expression of intercellular adhesion molecule 1 (CD54) by human alveolar epithelial cells. J Infect Dis (2002) 0.94
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Clin Vaccine Immunol (2009) 0.93
Human microbial challenge: the ultimate animal model. Lancet Infect Dis (2012) 0.93
Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis. FASEB J (2009) 0.92
Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential. Infect Immun (2004) 0.92
Anti-adhesion methods as novel therapeutics for bacterial infections. Expert Rev Anti Infect Ther (2012) 0.91
Tetraspanins: gateways for infection. Infect Disord Drug Targets (2012) 0.91
Identification of meningococcal genes necessary for colonization of human upper airway tissue. Infect Immun (2008) 0.91
Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease. PLoS One (2011) 0.91
ALS: life and death in a bad neighborhood. Nat Med (2006) 0.90
Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. J Infect Dis (2003) 0.90